Popular Articles

cure me

A National Autistic Society (NAS) Response To The National Audit Office (NAO) Report On Adults With Autism
Mark Lever, NAS chief executive said; "In the current economic climate the Government cannot possibly ignore the huge cost savings and benefits, identified by their own auditing body, of providing adults with autism with the right support at the right time. Neither the Government, people with autism nor the taxpayer are getting value for money from existing autism services and support, leaving those affected by the condition feeling isolated, ignored and often at breaking point. This is simply unacceptable.
Polygraphy
Tackling Major Health Challenges In England - The King's Fund Reveals New Approach To Supporting The NHS
The King"s Fund has announced a series of new initiatives and projects to take forward its work to improve health care.
News of the day
Policymakers To Discuss Alternatives To Custody
Experts in criminology will discuss "Alternatives to Custodial Sentencing" at a Parliamentary seminar organised by the British Psychological Society and the All-Party Parliamentary Group on Social Services and Policy. The event takes place at Westminster on Tuesday 16 June (4.30 - 6.00 p.m.)
Health Insurance

Research Carried Out In Mice Will Contribute To The Study Of Hereditary Diseases That Lead To Blindness

Researchers of the University of Granada (Spain) have used a technique consisting of the induction of neuronal degeneration neuronal for intense light exposure in the mouse"s retina that will be helpful for the study of retinitis pigmentosa (RP), a group of hereditary diseases which lead to blindness and affect more than one million persons a year all over the world. In addition, the results of this research work could be very useful for the detection of new factors or molecules originated by microglial cells and related to degenerative processes of the retina. The doctoral thesis of Ana Mara Santos Carro, researcher of the Department of Cell Biology of the University of Granada, is based on the study of microglial cells, a type of cell of the Nervous System that develop a phagocytic or purifying role against damages or infections in such system. Her work has analysed the distribution of microglial cells in la retina of the mouse during all its development, both embryonic and postnatal and adult, and has studied the response of these cells to a neurodegenerative process induced in the retina by intense light exposure. Parkinson"s and Alzheimer"s The researcher of the UGR insists that "it is important to get to know the response of the microglial cells against neurodegenerative, because such cells are practically involved in all the diseases and damages of the nervous system, including Parkinson"s and Alzheimer"s, and knowing their behaviour in pathologic situations could be helpful in the design of therapeutic strategies". Microglial cells are the resident population of macrophages in the central nervous system (CNS) and play a relevant role in the immune defence. The research group of the UGR "Embryology of the Nervous System" has been studying for years the origin, distribution and migratory characteristics of these cells, both in situations of normal development of the healthy CNS and in response to damages or injuries using as a model of study the retina of birds and mammals. Notes: The doctoral thesis of Ana Mara Santos Carro has been supervised by Professors Miguel ngel Cuadros Ojeda, Julio Navascus Martnez and Jos Luis Marn-Teva. Part of the results of this research work has been recently published in the specialized Journal of Comparative Neurology. Likewise, some of the results obtained have been presented in oral communications and posters in different national and international scientific meetings: VIII European Meeting on Glial Cell Functions in Health and Disease (Londres), VII European Meeting on Glial Cell Functions in Health and Disease (Amsterdam), IV Meeting of the Spanish Glial Network (Madrid), etc. Ana Mara Santos Carro University of Granada


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):